 |
 |

Metabolic Significance of Nonalcoholic Fatty Liver Disease in Nonobese, Nondiabetic Adults
Hae Jin Kim, MD;
Hyeong Jin Kim, MD;
Kwang Eun Lee, MD;
Dae Jung Kim, MD;
Soo Kyung Kim, MD;
Chul Woo Ahn, MD, PhD;
Sung-Kil Lim, MD, PhD;
Kyung Rae Kim, MD, PhD;
Hyun Chul Lee, MD, PhD;
Kap Bum Huh, MD, PhD;
Bong Soo Cha, MD, PhD
Arch Intern Med. 2004;164:2169-2175.
Background Obesity and type 2 diabetes are well-known risk factors for the development of nonalcoholic fatty liver disease (NAFLD). However, NAFLD is not rare in nonobese, nondiabetic adults. The aim of this study was to evaluate the metabolic significance of NAFLD in nonobese, nondiabetic adults.
Methods This study examined 768 nonobese (body mass index [BMI] [calculated as weight in kilograms divided by the square of height in meters], 18.5 and <30) (460 normal-weight and 308 overweight subjects), nondiabetic individuals older than 30 years who participated in a medical checkup. All the subjects had negative serologic findings for hepatitis B and C viruses and had an alcohol intake less than 140 g/wk. A standard interview, anthropometrics, a biochemical study, and abdominal ultrasonography were conducted.
Results The prevalence of NAFLD in the enrolled subjects was 23.4%. In the normal-weight (BMI, 18.5 and <25) and overweight (BMI, 25 and <30) groups, NAFLD was a significant predictor of insulin resistance and other metabolic disorders, including hypertriglyceridemia and hyperuricemia. The odds ratio of the metabolic disorders in subjects with NAFLD compared with those without NAFLD in the normal-weight groupwashigher than that in the overweight group. Multiplelogisticregression analysis showed that sex, waist circumference, triglyceride level, and insulin resistance wereindependentlyassociated with NAFLD in the normal-weight group.
Conclusions Nonalcoholic fatty liver disease is closely associated with metabolic disorders, even in nonobese, nondiabetic subjects. Nonalcoholic fatty liver disease can be considered an early predictor of metabolic disorders, particularly in the normal-weight population.
Author Affiliations: Division of Endocrinology and Metabolism, Department of Internal Medicine (Drs Hae J. Kim, K. E. Lee, S. K. Kim, Ahn, Lim, K. R. Kim, H. C. Lee, Huh, and Cha), and the Brain Korea 21 Project for Medical Science (Drs Lim, K. R. Kim, H. C. Lee, and Cha), Yonsei University College of Medicine, Seoul, Korea; Department of Internal Medicine, Kwan Dong University College of Medicine, Goyang, Korea (Dr Hyeong J. Kim); and Department of Endocrinology and Metabolism, Ajou University School of Medicine, Suwon, Korea (Dr D. J. Kim).
CiteULike Connotea Del.icio.us Digg Reddit Technorati Twitter
What's this?
RELATED LETTERS
Asians Need Different Criteria for Defining Overweight and Obesity
Radha K. Dhiman, Ajay Duseja, and Yogesh Chawla
Arch Intern Med. 2005;165(9):1069-1070.
EXTRACT
| FULL TEXT
Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease
Luca Mascitelli and Francesca Pezzetta
Arch Intern Med. 2005;165(9):1070.
EXTRACT
| FULL TEXT
Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver DiseaseReply
Hae Jin Kim, Soo Kyung Kim, and Bong Soo Cha
Arch Intern Med. 2005;165(9):1070.
EXTRACT
| FULL TEXT
THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES
 |
Weight gain within the normal weight range predicts ultrasonographically detected fatty liver in healthy Korean men
Chang et al.
Gut 2009;58:1419-1425.
ABSTRACT
| FULL TEXT
Causes and Metabolic Consequences of Fatty Liver
Stefan et al.
Endocr. Rev. 2008;29:939-960.
ABSTRACT
| FULL TEXT
The Metabolic Syndrome
Cornier et al.
Endocr. Rev. 2008;29:777-822.
ABSTRACT
| FULL TEXT
Nonalcoholic Fatty Liver Disease in Children
Manco et al.
J. Am. Coll. Nutr. 2008;27:667-676.
ABSTRACT
| FULL TEXT
Suppression of Diacylglycerol Acyltransferase-2 (DGAT2), but Not DGAT1, with Antisense Oligonucleotides Reverses Diet-induced Hepatic Steatosis and Insulin Resistance
Choi et al.
J. Biol. Chem. 2007;282:22678-22688.
ABSTRACT
| FULL TEXT
Comparative review of diets for the metabolic syndrome: implications for nonalcoholic fatty liver disease
Zivkovic et al.
Am. J. Clin. Nutr. 2007;86:285-300.
ABSTRACT
| FULL TEXT
Prenatal exposure to a low-protein diet programs disordered regulation of lipid metabolism in the aging rat
Erhuma et al.
Am. J. Physiol. Endocrinol. Metab. 2007;292:E1702-E1714.
ABSTRACT
| FULL TEXT
Influence of Hepatic Steatosis (Fatty Liver) on Severity and Composition of Dyslipidemia in Type 2 Diabetes
Toledo et al.
Diabetes Care 2006;29:1845-1850.
ABSTRACT
| FULL TEXT
Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease
Mascitelli and Pezzetta
Arch Intern Med 2005;165:1070-1070.
FULL TEXT
Asians Need Different Criteria for Defining Overweight and Obesity
Dhiman et al.
Arch Intern Med 2005;165:1069-1070.
FULL TEXT
Serum Ferritin Levels in Patients With Nonalcoholic Fatty Liver Disease--Reply
Kim et al.
Arch Intern Med 2005;165:1070-1070.
FULL TEXT
Nonalcoholic fatty liver disease
Adams et al.
CMAJ 2005;172:899-905.
ABSTRACT
| FULL TEXT
|